Nasus Pharma (NSRX) Stock: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.21
0.03 (0.95%)
▲
5d:
-3.31%
30d:
-9.06%
90d:
+5.94%
WAIT
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Jun 24, 2026
0d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.21, which is considered oversold relative to its 30-day fair value range of $3.30 to $3.73.
Technical Outlook: Technically, NSRX is in a uptrend. Immediate support is located at $3.05, while resistance sits at $3.91.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.67 (+518.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NSRX is in a uptrend. Immediate support is located at $3.05, while resistance sits at $3.91.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.67 (+518.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.30 -
$3.73
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 518.4% below Wall St target ($19.67)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.30 -
$3.73
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.05
Resistance Level
$3.91
Current Trend
Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.82
Wall Street Target
$19.67
(+518.4%)
Share & Embed Analysis
Last updated: October 19, 2026 2:20 PM ET
Data refreshes hourly during market hours. Next update: 3:20 PM
Data refreshes hourly during market hours. Next update: 3:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1328 | 37 SELL |
|
ABBV
AbbVie Inc |
STRONG BUY
30 analysts |
$283 | 40 SELL |
|
MRK
Merck & Company Inc |
STRONG BUY
27 analysts |
$158 | 54 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$160 | 34 SELL |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$244 | 36 SELL |